These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15504616)

  • 1. Future directions in research.
    Currier GW; Allen MH; Bunney EB; Daniel DG; Francis A; Jagoda A; Zimbroff D
    J Emerg Med; 2004 Nov; 27(4 Suppl):S27-9. PubMed ID: 15504616
    [No Abstract]   [Full Text] [Related]  

  • 2. Standard therapies for acute agitation.
    Currier GW; Allen MH; Bunney EB; Daniel DG; Francis A; Jagoda A; Zimbroff D
    J Emerg Med; 2004 Nov; 27(4 Suppl):S9-12; quiz S7. PubMed ID: 15504618
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neuroleptics: use in states of agitation].
    Dufour H; Tramoni AV; Colonne C
    Rev Prat; 1984 Mar; 34(13):597-8, 601-5. PubMed ID: 6143386
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel therapies for treating acute agitation.
    Currier GW; Allen MH; Bunney EB; Daniel DG; Francis A; Jagoda A; Zimbroff D
    J Emerg Med; 2004 Nov; 27(4 Suppl):S13-8. PubMed ID: 15504613
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of acute undifferentiated agitation in the emergency department.
    Holubek WJ; Dodge K; Hoffman RS
    Acad Emerg Med; 2006 May; 13(5):585; author reply 586-7. PubMed ID: 16641483
    [No Abstract]   [Full Text] [Related]  

  • 6. Interventions for the treatment of acute agitation.
    Citrome L
    CNS Spectr; 2007 Aug; 12(8 Suppl 11):8-12. PubMed ID: 19317015
    [No Abstract]   [Full Text] [Related]  

  • 7. Current attitudes regarding treatment of agitation and psychosis in dementia.
    Serby MJ; Roane DM; Lantz MS; Cohen AJ; Turok A; Perlis TE
    Am J Geriatr Psychiatry; 2009 Feb; 17(2):174. PubMed ID: 19155750
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologic interventions for psychosis and agitation in neurodegenerative diseases: evidence about efficacy and safety.
    Weintraub D; Katz IR
    Psychiatr Clin North Am; 2005 Dec; 28(4):941-83, ix-x. PubMed ID: 16325736
    [No Abstract]   [Full Text] [Related]  

  • 9. Professional consensus on the treatment of agitation, aggressive behaviour, oppositional behaviour and psychotic disturbances in dementia.
    Benoit M; Arbus C; Blanchard F; Camus V; Cerase V; Clement JP; Fremont P; Guerin O; Hazif Thomas C; Jeanblanc F; Lafont C; Moreaud O; Pedra M; Poncet M; Richard Harston S; Rigaud AS; Sotto Martin ME; Touchon J; Vellas B; Fitten LJ; Robert PH
    J Nutr Health Aging; 2006; 10(5):410-5. PubMed ID: 17066213
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of risperidone on nursing burden associated with caring for patients with dementia.
    Asghar Ali AA; Espinoza R; Kavirajan H; Read S
    J Am Geriatr Soc; 2005 Jul; 53(7):1261-2; author reply 1262-3. PubMed ID: 16108953
    [No Abstract]   [Full Text] [Related]  

  • 11. Clozapine use in treatment-resistant agitation in the setting of dementia.
    Bastiampillai T; Dhillon R; French TH
    Aust N Z J Psychiatry; 2009 Jul; 43(7):689-90. PubMed ID: 19530027
    [No Abstract]   [Full Text] [Related]  

  • 12. Agitation and psychosis in dementia.
    Ballard C
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):913-7. PubMed ID: 17974863
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of molindone in treatment-refractory agitated schizophrenia: three case reports.
    Ciranni M; Lindenmayer JP; Gold J
    J Clin Psychiatry; 2008 Jun; 69(6):1018-9. PubMed ID: 18684000
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antipsychotic drug therapy for patients with behavioral and psychological symptoms of dementia(BPSD)].
    Kudo T
    Seishin Shinkeigaku Zasshi; 2007; 109(7):657-63. PubMed ID: 17969953
    [No Abstract]   [Full Text] [Related]  

  • 15. Droperidol use in the emergency department is not safe.
    Prosser RL
    Acad Emerg Med; 2006 May; 13(5):585-6; author reply 586-7. PubMed ID: 16641482
    [No Abstract]   [Full Text] [Related]  

  • 16. Duration of risperidone treatment for BPSD.
    Snowdon J; Brodaty H; Ames D; Day S
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):699-701. PubMed ID: 16821255
    [No Abstract]   [Full Text] [Related]  

  • 17. Introduction: the clinical impact of agitation in various psychiatric disorders: management consensus and controversies.
    Mintzer JE
    J Clin Psychiatry; 2006; 67 Suppl 10():3-5. PubMed ID: 16965189
    [No Abstract]   [Full Text] [Related]  

  • 18. Clozapine for treatment-resistant agitation in dementia.
    Lee HB; Hanner JA; Yokley JL; Appleby B; Hurowitz L; Lyketsos CG
    J Geriatr Psychiatry Neurol; 2007 Sep; 20(3):178-82. PubMed ID: 17712102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of medications used to treat acute agitation.
    Currier GW; Allen MH; Bunney EB; Daniel DG; Francis A; Jagoda A; Zimbroff D
    J Emerg Med; 2004 Nov; 27(4 Suppl):S19-24. PubMed ID: 15504614
    [No Abstract]   [Full Text] [Related]  

  • 20. To prescribe or not to prescribe? Atypical antipsychotic drugs in patients with dementia.
    Jeste DV; Meeks T
    South Med J; 2007 Oct; 100(10):961-3. PubMed ID: 17943030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.